Literature DB >> 2313742

Effects of perfluoro-n-decanoic acid on the respiratory activity of isolated rat liver mitochondria.

A E Langley1.   

Abstract

The toxic responses of rats to a single dose of perfluorodecanoic acid (PFDA) include reduced food consumption, severe body weight loss ("wasting syndrome"), and hypothermia. Recent studies have suggested that some of these effects may be due to alterations of basic metabolic processes in animals treated with PFDA. In order to test this hypothesis the effects of PFDA on respiratory activity of isolated rat liver mitochondria were examined. PFDA concentrations up to 87.5 micrograms/ml produced a linear increase in oxygen consumption during state 4 (nonphosphorylating) respiration. This suggested uncoupling of electron transport and oxidative phosphorylation was supported by the observation that PFDA released mitochondrial state 3 respiration from inhibition by oligomycin and stimulated latent ATPase activity. Concentrations of PFDA greater than 87.5 micrograms/ml produced progressively less increase in state 4 oxygen consumption, and a single high concentrations (150 micrograms/ml) completely inhibited state 3 respiration and prevented the uncoupling effect of 2,4-dinitrophenol. These observations suggest that in addition to uncoupling electron transport and oxidative phosphorylation PFDA may affect other energy-transducing functions of liver mitochondria such as inhibiting electron transport. These effects on mitochondrial respiration may help to explain the "wasting syndrome" characteristic of PFDA toxicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2313742     DOI: 10.1080/15287399009531395

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  9 in total

1.  Perfluorooctane sulfonate increases β-oxidation of palmitic acid in chicken liver.

Authors:  Marcus Nordén; Ola Westman; Nikolaos Venizelos; Magnus Engwall
Journal:  Environ Sci Pollut Res Int       Date:  2012-03-23       Impact factor: 4.223

2.  Effect of contaminants of emerging concern on liver mitochondrial function in Chinook salmon.

Authors:  Andrew Yeh; David J Marcinek; James P Meador; Evan P Gallagher
Journal:  Aquat Toxicol       Date:  2017-06-16       Impact factor: 4.964

3.  Structure-activity relationships for perfluoroalkane-induced in vitro interference with rat liver mitochondrial respiration.

Authors:  K B Wallace; G E Kissling; R L Melnick; C R Blystone
Journal:  Toxicol Lett       Date:  2013-08-14       Impact factor: 4.372

4.  Phytochemical Studies, Antioxidant Potential, and Identification of Bioactive Compounds Using GC-MS of the Ethanolic Extract of Luffa cylindrica (L.) Fruit.

Authors:  Ankul Singh S; Chitra Vellapandian
Journal:  Appl Biochem Biotechnol       Date:  2022-05-18       Impact factor: 3.094

5.  The toxicity of perfluorodecanoic acid is mainly manifested as a deflected immune function.

Authors:  Keming Li; Qian Zhao; Ziyan Fan; Shouyin Jia; Qing Liu; Fengyan Liu; Shili Liu
Journal:  Mol Biol Rep       Date:  2022-03-02       Impact factor: 2.742

6.  Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers.

Authors:  Xingguo Cheng; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2008-08-14       Impact factor: 4.849

7.  The effects of perfluoro-octanoic acid on hepatic peroxisome proliferation and related parameters show no sex-related differences in mice.

Authors:  A K Sohlenius; K Andersson; J W DePierre
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

8.  Perfluorocarboxylic acids induce cytochrome P450 enzymes in mouse liver through activation of PPAR-alpha and CAR transcription factors.

Authors:  Xingguo Cheng; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2008-07-22       Impact factor: 4.849

9.  Perfluorodecanoic acid (PFDA) promotes gastric cell proliferation via sPLA2-IIA.

Authors:  Tianyi Dong; Yanping Peng; Ning Zhong; Fengyan Liu; Hanyu Zhang; Mengchen Xu; Rutao Liu; Mingyong Han; Xingsong Tian; Jihui Jia; Lap Kam Chang; Liang-Hong Guo; Shili Liu
Journal:  Oncotarget       Date:  2017-04-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.